Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab for Chronic Rhinosinusitis with Nasal Polyposis
NCT01066104Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2009
- Primary completion
- Jul 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing Omalizumab with Placebo (2 arms). Primary endpoint: Polypoid Mucosal Thickening in the Anterior Ethmoid and Maxillary Sinuses at 4 months. Started Dec 2009; status: completed.
02
Drugs
omalizumab
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT01066104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066104.